The inactivation of RUNX3 in a variety of solid tumors has also been identified as an important tumor oncogenic factor.RUNX3 has been reported to act as a tumor suppressor in melanoma (30), gastric cancer (31) and lung cancer (32), inhibited tumor progression and metastasis. This evidence concerns the gene RUNX3 and gastric cancer.